Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Prospective, Randomized Comparison of 2 Doses of MitoQ and Placebo for the Treatment of Patients With Parkinson's Disease

NCT00329056 is registered in ClinicalTrials.gov with Antipodean Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00329056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00329056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Prospective, Randomized Comparison of 2 Doses of MitoQ and Placebo for the Treatment of Patients With Parkinson's Disease
Lead sponsor
Antipodean Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2006
Completion date
November 30, 2007
Enrollment
128 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease